North America Intravenous IV Therapy and Vein Access Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends
Top Countries — Revenue
Access the full forecast model.
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
North America Intravenous IV Therapy and Vein Access Market Analysis — Presence
Geographical Analysis
Click countries to exploreCountry Analysis
North America Intravenous IV Therapy and Vein Access Market Analysis 2026
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| North America Intravenous IV Therapy and Vein Access Total | xxxx | xxxx | xxxx | 3.7% |
| United States | xxxx | xxxx | xxxx | 3.5% |
| Canada | xxxx | xxxx | xxxx | 4.5% |
| Mexico | xxxx | xxxx | xxxx | 4.2% |
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Segmentation Analysis
Type breakdown · Illustrative 2025 shares shown free · Full-period forecast in paid report.
Disclaimer: The charts and graphs are for illustrative purposes only and do not represent actual market values. To access accurate quantitative data, please request a paid report or request free sample.
To learn more about market share and segmentation, request the free sample pages.
Competitor Analysis
Competitive Landscape of the Intravenous IV Therapy and Vein Access Market
The market players are prioritizing innovation, providing innovative items such as antimicrobial catheters, needleless systems, and smart infusion pumps. Smaller and growing firms contribute by offering specialized products and expanding regionally. Technological developments, cost-effectiveness, product safety, and regulatory compliance all contribute to competitiveness. Partnerships, acquisitions, and product launches are prominent strategies for increasing market share in this booming yet regulated business.
In November 2023, BD (Becton, Dickinson, and Company), a leading global medical technology company, introduced a new advanced ultrasound system to help clinicians place peripherally inserted central catheters (PICCs), central venous catheters, IV lines, and other vascular access devices more efficiently. (Source: https://news.bd.com/2023-11-30-BD-Launches-Advanced-Vascular-Access-Ultrasound-System-Designed-to-Improve-Clinician-Efficiency ) In March 2022, Fresenius Kabi, a global healthcare company, signed an agreement to acquire Ivenix's enhanced infusion system, which will be integrated into Fresenius Kabi's intravenous fluids and infusion therapy portfolio, bringing a broad offering of blended products to U.S. hospitals. (Source: https://www.fresenius-kabi.com/news/fresenius-kabi-completes-acquisition-of-ivenix-inc ) In May 2021, Smiths Medical entered into a cooperation with Ivenix, a medical technology business. The companies hoped that this collaboration would allow them to provide a comprehensive range of infusion management solutions. Furthermore, Smiths Medical would make a strategic investment in the long-term relationship, which aspires to redefine blended management and improve patient health while meeting the needs of a healthcare supplier. (Source: https://www.businesswire.com/news/home/20210504005275/en/Smiths-Medical-and-Ivenix-Partner-to-Revolutionize-Infusion-Management-with-First-Ever-Comprehensive-Suite-of-Infusion-Solutions-in-US-Healthcare-Market )| Top Companies (In no particular order) | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Company 1 | ••• | ••• | ••• | ••• |
| Company 2 | ••• | ••• | ••• | ••• |
| Company 3 | ••• | ••• | ••• | ••• |
| Company 4 | ••• | ••• | ••• | ••• |
| Company 5 | ••• | ••• | ••• | ••• |
We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.
Request company profile for validation →Report Scope & Analysis
According to Cognitive Market Research, the global Intravenous IV Therapy and Vein Access Market size was estimated at USD 25415.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 10166.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.
- According to Cognitive Market Research, the US had a major share in the Intravenous IV Therapy and Vein Access Market with a market size of USD 8021.04 million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period. In U.S adoption of the advanced IV technologies.
- The Canada Intravenous IV Therapy and Vein Access Market had a market share of USD 1219.93 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. An older population increases demand for IV therapy in Canada.
- The Mexico Intravenous IV Therapy and Vein Access Market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 925.11 million in 2024.
Analyst Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The North America Intravenous IV Therapy and Vein Access Market Analysis is witnessing significant growth in the near future.
In 2023, the Implantable Ports segment accounted for a notable share of the North America Intravenous IV Therapy and Vein Access Market Analysis.
Chidanand Bilagi is a Senior Research Associate at Cognitive Market Research and Consulting, specializing in the chemical and materials industry. With a strong focus on global chemical markets, advanced materials, specialty chemicals, sustainable materials, and emerging industrial innovations, he delivers in-depth market intelligence and strategic insights to support informed decision-making.
His expertise includes analyzing industry trends, competitive landscapes, supply chain dynamics, regulatory developments, raw material pricing patterns, and technological advancements shaping the future of the chemical and materials sector. Through rigorous research and data-driven analysis, Chidanand contributes to the development of comprehensive market reports, helping businesses, investors, and industry stakeholders identify opportunities and address challenges in an evolving global market landscape.
Frequently Asked Questions
★ Reviews
Rate this report
North America Intravenous IV Therapy and Vein Access Market Analysis — Table of Contents
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Report Scope
| Type | Implantable Ports, Intravenous Catheters, Hypodermic Needles, Infusion Pumps, Other |
|---|---|
| Medical Application | Nutrition And Buffer Solution, Volume Expander, Medication Administration, Blood Based Products |
| End Use | Hospitals, Ambulatory Surgical Center, Clinics |
| List of Competitors | smiths medical, AngioDynamics, Inc., Teleflex, Fresenius SE and Co. KGaA., Pfizer Inc, Medtronic Inc, Cardinal Health Inc., B. Braun Melunsung, terumo corporation, Baxter international plc |
Chapter 1. Competitor Analysis (Subject to Data Availability (Private Players))
- 1.1 Top Competitors Analysis
- 1.1.1 Top Players Ranking 2024
- 1.1.2 New Product Launch Analysis
- 1.2 Company Profile (Data Subject to Availability) Sample Format
- 1.2.1 smiths medical
- 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.1.2 Business Overview
- 1.2.1.3 R&D Investment (Subject to data availability)
- 1.2.1.4 Financials (Subject to data availability)
- 1.2.1.5 Product Types Specification
- 1.2.1.6 Business Strategy
- 1.2.1.7 Recent Developments
- 1.2.1.8 Management Change
- 1.2.1.9 S.W.O.T Analysis
- 1.2.2 AngioDynamics
- 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.2.2 Business Overview
- 1.2.2.3 R&D Investment (Subject to data availability)
- 1.2.2.4 Financials (Subject to data availability)
- 1.2.2.5 Product Types Specification
- 1.2.2.6 Business Strategy
- 1.2.2.7 Recent Developments
- 1.2.2.8 Management Change
- 1.2.2.9 S.W.O.T Analysis
- 1.2.3 Inc.
- 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.3.2 Business Overview
- 1.2.3.3 R&D Investment (Subject to data availability)
- 1.2.3.4 Financials (Subject to data availability)
- 1.2.3.5 Product Types Specification
- 1.2.3.6 Business Strategy
- 1.2.3.7 Recent Developments
- 1.2.3.8 Management Change
- 1.2.3.9 S.W.O.T Analysis
- 1.2.4 Teleflex
- 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.4.2 Business Overview
- 1.2.4.3 R&D Investment (Subject to data availability)
- 1.2.4.4 Financials (Subject to data availability)
- 1.2.4.5 Product Types Specification
- 1.2.4.6 Business Strategy
- 1.2.4.7 Recent Developments
- 1.2.4.8 Management Change
- 1.2.4.9 S.W.O.T Analysis
- 1.2.5 Fresenius SE and Co. KGaA.
- 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.5.2 Business Overview
- 1.2.5.3 R&D Investment (Subject to data availability)
- 1.2.5.4 Financials (Subject to data availability)
- 1.2.5.5 Product Types Specification
- 1.2.5.6 Business Strategy
- 1.2.5.7 Recent Developments
- 1.2.5.8 Management Change
- 1.2.5.9 S.W.O.T Analysis
- 1.2.6 Pfizer Inc
- 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.6.2 Business Overview
- 1.2.6.3 R&D Investment (Subject to data availability)
- 1.2.6.4 Financials (Subject to data availability)
- 1.2.6.5 Product Types Specification
- 1.2.6.6 Business Strategy
- 1.2.6.7 Recent Developments
- 1.2.6.8 Management Change
- 1.2.6.9 S.W.O.T Analysis
- 1.2.7 Medtronic Inc
- 1.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.7.2 Business Overview
- 1.2.7.3 R&D Investment (Subject to data availability)
- 1.2.7.4 Financials (Subject to data availability)
- 1.2.7.5 Product Types Specification
- 1.2.7.6 Business Strategy
- 1.2.7.7 Recent Developments
- 1.2.7.8 Management Change
- 1.2.7.9 S.W.O.T Analysis
- 1.2.8 Cardinal Health Inc.
- 1.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.8.2 Business Overview
- 1.2.8.3 R&D Investment (Subject to data availability)
- 1.2.8.4 Financials (Subject to data availability)
- 1.2.8.5 Product Types Specification
- 1.2.8.6 Business Strategy
- 1.2.8.7 Recent Developments
- 1.2.8.8 Management Change
- 1.2.8.9 S.W.O.T Analysis
- 1.2.9 B. Braun Melunsung
- 1.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.9.2 Business Overview
- 1.2.9.3 R&D Investment (Subject to data availability)
- 1.2.9.4 Financials (Subject to data availability)
- 1.2.9.5 Product Types Specification
- 1.2.9.6 Business Strategy
- 1.2.9.7 Recent Developments
- 1.2.9.8 Management Change
- 1.2.9.9 S.W.O.T Analysis
- 1.2.10 terumo corporation
- 1.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.10.2 Business Overview
- 1.2.10.3 R&D Investment (Subject to data availability)
- 1.2.10.4 Financials (Subject to data availability)
- 1.2.10.5 Product Types Specification
- 1.2.10.6 Business Strategy
- 1.2.10.7 Recent Developments
- 1.2.10.8 Management Change
- 1.2.10.9 S.W.O.T Analysis
- 1.2.11 Baxter international plc
- 1.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.11.2 Business Overview
- 1.2.11.3 R&D Investment (Subject to data availability)
- 1.2.11.4 Financials (Subject to data availability)
- 1.2.11.5 Product Types Specification
- 1.2.11.6 Business Strategy
- 1.2.11.7 Recent Developments
- 1.2.11.8 Management Change
- 1.2.11.9 S.W.O.T Analysis
- 1.2.1 smiths medical
- 1.1 Top Competitors Analysis
Chapter 2. Global Intravenous IV Therapy and Vein Access Market Analysis
- 2.1 Global Intravenous IV Therapy and Vein Access Market Analysis
- 2.2 Global Intravenous IV Therapy and Vein Access Market Analysis by Type
- 2.3 Global Intravenous IV Therapy and Vein Access Market Analysis by Medical Application
- 2.4 Global Intravenous IV Therapy and Vein Access Market Analysis by End Use
Chapter 3. North America Intravenous IV Therapy and Vein Access Market Analysis
- 3.1 North America Intravenous IV Therapy and Vein Access Market Analysis
- 3.2 North America Intravenous IV Therapy and Vein Access Market Analysis by Country
- 3.3 North America Intravenous IV Therapy and Vein Access Market Analysis by Type
- 3.4 North America Intravenous IV Therapy and Vein Access Market Analysis by Medical Application
- 3.5 North America Intravenous IV Therapy and Vein Access Market Analysis by End Use
- 3.6 North America Intravenous IV Therapy and Vein Access Market Analysis by Key Players
Chapter 4. United States Intravenous IV Therapy and Vein Access Market Analysis
- 4.1 United States Intravenous IV Therapy and Vein Access Market Analysis
- 4.2 United States Intravenous IV Therapy and Vein Access Market Analysis by Type
- 4.3 United States Intravenous IV Therapy and Vein Access Market Analysis by Medical Application
- 4.4 United States Intravenous IV Therapy and Vein Access Market Analysis by End Use
- 4.5 United States Intravenous IV Therapy and Vein Access Market Analysis by Key Players
Chapter 5. Canada Intravenous IV Therapy and Vein Access Market Analysis
- 5.1 Canada Intravenous IV Therapy and Vein Access Market Analysis
- 5.2 Canada Intravenous IV Therapy and Vein Access Market Analysis by Type
- 5.3 Canada Intravenous IV Therapy and Vein Access Market Analysis by Medical Application
- 5.4 Canada Intravenous IV Therapy and Vein Access Market Analysis by End Use
- 5.5 Canada Intravenous IV Therapy and Vein Access Market Analysis by Key Players
Chapter 6. Mexico Intravenous IV Therapy and Vein Access Market Analysis
- 6.1 Mexico Intravenous IV Therapy and Vein Access Market Analysis
- 6.2 Mexico Intravenous IV Therapy and Vein Access Market Analysis by Type
- 6.3 Mexico Intravenous IV Therapy and Vein Access Market Analysis by Medical Application
- 6.4 Mexico Intravenous IV Therapy and Vein Access Market Analysis by End Use
- 6.5 Mexico Intravenous IV Therapy and Vein Access Market Analysis by Key Players
Chapter 7. Type Analysis
- 7.1 Implantable Ports
- 7.2 Intravenous Catheters
- 7.3 Hypodermic Needles
- 7.4 Infusion Pumps
- 7.5 Other
Chapter 8. Medical Application Analysis
- 8.1 Nutrition And Buffer Solution
- 8.2 Volume Expander
- 8.3 Medication Administration
- 8.4 Blood Based Products
Chapter 9. End Use Analysis
- 9.1 Hospitals
- 9.2 Ambulatory Surgical Center
- 9.3 Clinics
Chapter 10. Qualitative Analysis (Subject to Data Availability)
- 10.1 Market Drivers
- 10.2 Market Restraints
- 10.3 Market Trends
- 10.4 Market Opportunity
- 10.5 Technological Road Map (Subject to Data Availability)
- 10.6 Product Life Cycle (Subject to Data Availability)
- 10.7 Customer and Buyer Behavior Analysis
- 10.7.1 Digital Engagement, Customer Experience & Relationship Analysis
- 10.7.2 Customer Buying Behavior & Purchase Decision Analysis
- 10.7.3 Vendor Selection, Supplier Preferences & Future Demand Trends
- 10.7.4 Pricing, Affordability & Value Perception Analysis
- 10.7.5 Customer Segmentation & Demand Pattern Analysis
- 10.8 Industrial Chain Analysis (Subject to Data Availability)
- 10.8.1 Industry Chain Analysis
- 10.8.2 Manufacturing Cost Analysis
- 10.8.3 Supply Side Analysis
- 10.8.3.1 Raw Material Analysis
- 10.8.3.2 Raw Material Procurement Analysis
- 10.8.3.3 Raw Material Price Trend Analysis
- 10.9 PESTEL Analysis
- 10.9.1 Environmental Factors
- 10.9.2 Legal Factors
- 10.9.3 Technological Factors
- 10.9.4 Economic Factors
- 10.9.5 Political Factors
- 10.9.6 Social Factors
- 10.10 Porter’s Five Forces Analysis
- 10.10.1 Degree of Competition
- 10.10.2 Threat of Substitutes
- 10.10.3 Threat of New Entrants
- 10.10.4 Bargaining Power of Buyers
- 10.10.5 Bargaining Power of Suppliers
- 10.11 Patent Analysis (Subject to Data Availability)
- 10.12 ESG Analysis
- 10.13 Geopolitical Outlook
- 10.13.1 Global Power Realignment & Strategic Alliances
- 10.13.2 Geopolitical Risk Landscape & Conflict Hotspots
- 10.13.3 International Trade Relations & Market Access Environment
- 10.13.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
- 10.13.5 Supply Chain Resilience, Localization & Resource Nationalism
- 10.13.6 Technology Sovereignty & Digital Geopolitics
- 10.13.7 Strategic Implications for Investment, Growth & Market Entry
- 10.14 AI & Market Transformation
- 10.14.1 Competitive Landscape Disruption & Strategic Shifts
- 10.14.2 AI-Driven Transformation of Industry Value Chain
- 10.14.3 Evolution of Business Models & Revenue Streams
- 10.14.4 AI-Driven Product, Service & Innovation Transformation
- 10.14.5 Customer Behavior, AI Adoption & Future Market Evolution
Chapter 11. Research Findings
- 11.1 Key Takeaways
- 11.2 Analyst Point of View
- 11.3 Assumptions and Acronyms
Chapter 12. Research Methodology and Sources
- 12.1 Primary Data Collection
- 12.1.1 Steps for Primary Data Collection
- 12.1.1.1 Identification of KOL
- 12.1.2 Backward Integration
- 12.1.3 Forward Integration
- 12.1.4 How Primary Research Help Us
- 12.1.5 Modes of Primary Research
- 12.1.1 Steps for Primary Data Collection
- 12.2 Secondary Research
- 12.2.1 How Secondary Research Help Us
- 12.2.2 Sources of Secondary Research
- 12.3 Data Validation
- 12.3.1 Data Triangulation
- 12.4 Data Representation
- 12.1 Primary Data Collection
Athenaeum AI Dashboard
Our Proprietary Methodology
Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Chidanand Bilagi and team for the North America Intravenous IV Therapy and Vein Access Market Analysis Market analysis.
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
Data Assurance Metrics
Analytical Coverage
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
Sources from the Chemical and Materials Industry
The Three Pillars of End-to-End Market Research Services
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the North America Intravenous IV Therapy and Vein Access Market Analysis market.
Market Survey
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the north america intravenous iv therapy and vein access market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
- Buyer intent & sentiment analysis
- Purchase cycle mapping
- Price sensitivity research
- Channel preference profiling
- Competitive perception study
Customized Market Data & Reports
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
- Ready syndicate report
- Custom data scope & segmentation
- Excel quantitative models
- Board-ready PPT with key findings
- Secure cloud portal access
Strategic Consultation
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
- Dedicated analyst assigned to you
- Live walkthrough of findings
- Strategic Q&A sessions
- Go-to-market recommendations
- NDA-protected engagement
Customize This Report
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
